The 2024 Auditor General’s report, which was tabled in the National Assembly yesterday, found that several types of drugs and medications purchased more than three years ago by the Ministry of Health are yet to be delivered.
According to the report outstanding deliveries amounted to $3.607 billion as at September 2025. While $94.082M of drugs purchased in 2022 and 2023 are yet to be delivered.
Additionally, the report found that during the period August 2024 to April 2025, a quantity of drugs valued at $1.098 billion were expired and disposed of by the Ministry of Health, while a further $327.293M of drugs was on hand to be thrown out.
The sum of $10.216 billion was allotted for drugs and medical supplies last year with
a supplementary allocation of $3.687 billion, giving a revised total of $14.006 billion.
A total $13.993 billion were expended.
Included in this amount was $117.482M for warrants, $102M for Linden Hospital Complex and $89.230M for Georgetown Public Hospital Corporation. The difference of $13.684 billion were paid to Suppliers.
“At the time of reporting in September 2025, outstanding deliveries totalled $3.607 billion while excess deliveries totaled to $70.510M. It should be noted that the Ministry submitted additional Invoices, Stores Received Notes and Delivery Notes for Drugs and Medical Supplies valued at $951.393M. The Audit Office is in the process of validating those deliveres,” the Audit Office said in its report.
Among the main suppliers of drugs and medical supplies are New GPC Inc. And Western Scientific Company Ltd.
In response to the issues raised by the Audit Office, the Health Ministry had indicated that due to space constraints, it is normal practice in the health supply chain to expect changes in delivery times for medicines and supplies after contracts are signed, due to unexpected demand patterns as a result of pandemics, It also noted that short shelf life of medical supplies, natural disasters, and illness profiles for some of the delays.
The Ministry has also noted that it is in the process of closing these contracts with the suppliers for the outstanding deliveries of $80.231M and $13.851M.
The Audit Office has recommended that the Ministry take action to ensure that Suppliers of Drugs and Medical Supplies honour their contractual obligations.













You must be logged in to post a comment Login